Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
10,649,302
-
Share change
-
+1,596,144
-
Total reported value
-
$133,651,633
-
Price per share
-
$12.55
-
Number of holders
-
50
-
Value change
-
+$20,036,772
-
Number of buys
-
24
-
Number of sells
-
20
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q3 2022
As of 30 Sep 2022,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,649,302 shares.
The largest 10 holders included
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Private Advisor Group, LLC, Mirae Asset Global Investments Co., Ltd., McGuire Investment Group, LLC, One Capital Management, LLC, Portland Global Advisors LLC, ROYAL BANK OF CANADA, UBS Group AG, Raymond James Financial Services Advisors, Inc., and HighTower Advisors, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.